Cleared Traditional

MEDIPALM-20 (K031202) - FDA 510(k) Clearance

Class II Neurology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K031202 · Braebon Medical Corp. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2003
Decision
15d
Days
Class 2
Risk

K031202 is an FDA 510(k) clearance for the MEDIPALM-20. Classified as Standard Polysomnograph With Electroencephalograph (product code OLV), Class II - Special Controls.

Submitted by Braebon Medical Corp. (Carp, Ontario, CA). The FDA issued a Cleared decision on May 1, 2003 after a review of 15 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1400 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Braebon Medical Corp. devices

Submission Details

510(k) Number K031202 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 16, 2003
Decision Date May 01, 2003
Days to Decision 15 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Regulatory Context
Review time vs. panel average
133d faster than avg
Panel avg: 148d · This submission: 15d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

Device Classification

Product Code OLV Standard Polysomnograph With Electroencephalograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1400
Definition Acquire, Display, Store, And Archive Electroencephalographic Signals From The Brain And Other Signals (such As Electromyography, Respiratory And/or Oximetry Signals) For Sleep Recordings. May Also Be Used To Allow On-screen Review, User-controlled Annotation And User-controlled Marking Of Data.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - OLV Standard Polysomnograph With Electroencephalograph

All 19
Devices cleared under the same product code (OLV) and FDA review panel - the closest regulatory comparables to K031202.
EEG-1100A SWITCH BOX
K073491 · Nihon Kohden America, Inc. · Jan 2008
ELECTRODE JUNCTION BOX, MODEL JE-921A
K050833 · Nihon Kohden America, Inc. · Apr 2005
WIRELESS INPUT UNIT, MODEL WEE-1000A SERIES
K033475 · Nihon Kohden America, Inc. · Jan 2004
PSG INPUT BOX, MODEL JE-912AK
K022121 · Nihon Kohden America, Inc. · Jul 2002
NEUROFAX, MODELS EEG-1100A, EEG-9100A
K011204 · Nihon Kohden America, Inc. · May 2001
VITAPORT 3
K000338 · Nihon Kohden America, Inc. · Apr 2000